proMMP9-IN-3c manufacturers
|
| | proMMP9-IN-3c Basic information |
| Product Name: | proMMP9-IN-3c | | Synonyms: | proMMP9-IN-3c;Butanamide, N-(4-fluorophenyl)-4-[(3,4,5,6,7,8-hexahydro-4-oxo-2-quinazolinyl)thio]-;ProMMP-9 inhibitor-3c | | CAS: | 2138321-18-1 | | MF: | C18H20FN3O2S | | MW: | 361.43 | | EINECS: | | | Product Categories: | | | Mol File: | 2138321-18-1.mol |  |
| | proMMP9-IN-3c Chemical Properties |
| density | 1.37±0.1 g/cm3(Predicted) | | pka | 13.68±0.70(Predicted) |
| | proMMP9-IN-3c Usage And Synthesis |
| Description | ProMMP-9 inhibitor-3c is a potent and specific proMMP-9 inhibitor which disrupts f MMP-9 homodimerization and prevents association of proMMP-9 with both α4β1 integrin and CD44 and results in the dissociation of EGFR. | | Uses | proMMP-9 inhibitor-3c (compound 3c) is a potent proMMP-9 inhibitor. proMMP-9 inhibitor-3c is specific for binding to the proMMP-9 hemopexin-like domain (Kd=320 nM). proMMP-9 inhibitor-3c disruption of MMP-9 homodimerization prevents association of proMMP-9 with both α4β1 integrin and CD44 and results in the dissociation of EGFR. This disruption results in decreased phosphorylation of Src and its downstream target proteins focal adhesion kinase (FAK) and paxillin (PAX)[1]. | | References | [1] Alford VM, et al. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions. ACS Chem Biol. 2017 Nov 17;12(11):2788-2803. DOI:10.1021/acschembio.7b00758 |
| | proMMP9-IN-3c Preparation Products And Raw materials |
|